Holen Sie sich die Stockscreener-App
1.44
1.37%
-0.02
Handel nachbörslich:
1.43
-0.01
-0.69%
Schlusskurs vom Vortag:
$1.46
Offen:
$1.46
24-Stunden-Volumen:
246.31K
Relative Volume:
0.86
Marktkapitalisierung:
$43.30M
Einnahmen:
$210.70K
Nettoeinkommen (Verlust:
$-21.37M
KGV:
-1.3091
EPS:
-1.1
Netto-Cashflow:
$-21.10M
1W Leistung:
-14.79%
1M Leistung:
-8.28%
6M Leistung:
-32.39%
1J Leistung:
+35.85%
1-Tages-Spanne:
$1.41
$1.52
1-Wochen-Bereich:
$1.41
$1.69
52-Wochen-Spanne:
$0.89
$3.19
Gain Therapeutics Inc Stock (GANX) Company Profile
Firmenname
Gain Therapeutics Inc
Sektor
Branche
Telefon
(301) 500-1556
Adresse
4800 HAMPDEN LANE, BETHESDA
Vergleichen Sie GANX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GANX
Gain Therapeutics Inc
|
1.44 | 50.47M | 210.70K | -21.37M | -21.10M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Gain Therapeutics Inc Stock (GANX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-12-06 | Eingeleitet | ROTH MKM | Buy |
| 2024-08-14 | Fortgesetzt | Oppenheimer | Outperform |
| 2021-04-12 | Eingeleitet | BTIG Research | Buy |
| 2021-04-12 | Eingeleitet | Oppenheimer | Outperform |
Gain Therapeutics Inc Aktie (GANX) Neueste Nachrichten
How does Gain Therapeutics Inc. compare to its industry peersAccelerated capital growth - jammulinksnews.com
How does Gain Therapeutics Inc. generate profit in a changing economyConsistent triple returns - jammulinksnews.com
Is Gain Therapeutics Inc. stock overvalued or undervaluedInvest confidently with expert support - jammulinksnews.com
What are the latest earnings results for Gain Therapeutics Inc.Grow your wealth with proven stock picks - jammulinksnews.com
Published on: 2025-08-02 05:35:53 - Newser
Using flow based indicators on Gain Therapeutics Inc.Annual Market Behavior and Sector Summary - Newser
Evaluating Gain Therapeutics Inc. with trendline analysisConsistent Return Setup with Exit Strategy - Newser
What is the risk reward ratio of investing in Gain Therapeutics Inc. stockMarket Forecast Updates That Work - jammulinksnews.com
Why Gain Therapeutics Inc. stock attracts strong analyst attentionLong-Term Allocation Strategy Summary Breakdown - Newser
What makes Gain Therapeutics Inc. stock price move sharplyFree Real-Time Analysis With Entry Targets - Newser
RSI Reset May Fuel Rebound in Gain Therapeutics Inc.Smart Allocation Stock Pick Insights Gaining Interest - metal.it
Fibonacci Retracement Aligns with Support in Gain Therapeutics Inc.Market Surge Signal for Swing Traders Triggered - metal.it
What analysts say about Gain Therapeutics Inc. stock outlookSmart Swing Picks with Confirmed Signals - Newser
What are analysts’ price targets for Gain Therapeutics Inc. in the next 12 monthsFinancial News Planner For Consistent Profits - jammulinksnews.com
Published on: 2025-07-28 18:37:30 - metal.it
Is it the right time to buy Gain Therapeutics Inc. stockOverwhelming profit margins - jammulinksnews.com
How Resilient Is Gain Therapeutics Inc. Stock During Economic DownturnsPattern Recognition Tool for ROI Investors - Newser
Why is Gain Therapeutics Inc. stock attracting strong analyst attentionCapitalize on stocks with high profit margins - jammulinksnews.com
Candlestick signals on Gain Therapeutics Inc. stock today Watchlist Summary for Active Day Traders - Newser
What analysts say about Gain Therapeutics Inc. stock outlook Short-Term Upside Breakout Forecast System - Newser
What is the dividend policy of Gain Therapeutics Inc. stockUnmatched profit potential - jammulinksnews.com
What catalysts could drive Gain Therapeutics Inc. stock higher in 2025Skyrocketing profit margins - jammulinksnews.com
Should I hold or sell Gain Therapeutics Inc. stock in 2025High-velocity gains - jammulinksnews.com
Sectors Driving Future Growth for Gain Therapeutics Inc. StockLow Risk Consistent Winners - Newser
What analysts say about Gain Therapeutics Inc. stockHigh-yield growth strategies - PrintWeekIndia
Gain Therapeutics Inc. Stock Analysis and ForecastOutstanding risk-reward balance - PrintWeekIndia
Is Gain Therapeutics Inc. a good long term investmentOutstanding capital returns - Autocar Professional
What makes Gain Therapeutics Inc. stock attractive to long term investorsExplosive market performance - jammulinksnews.com
Gain Therapeutics to Present at BTIG Annual Virtual Biotechnology Conference - The Manila Times
Gain Therapeutics to Present at BTIG's Annual Biotechnology Conference. - AInvest
Gain Therapeutics Leadership Team Set for Exclusive Fireside Chat at BTIG Annual Biotech Conference - Stock Titan
Is Indaptus Therapeutics Inc. a good long term investmentRapid market gains - jammulinksnews.com
Finanzdaten der Gain Therapeutics Inc-Aktie (GANX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):